MiMedx Group, Inc. Restructuring and Related Cost, Number of Positions Eliminated
MiMedx Group, Inc. (MDXG) reported Restructuring and Related Cost, Number of Positions Eliminated of 240 position for the 1-month period ending 2018-12-31, per its 10-K filed 2022-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2023-02-28
- 2018-12-31: Restructuring and Related Cost, Number of Positions Eliminated 1 month 240.00 position.
position
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 1 month |
|---|---|
| 2018-12-31 | 240.00 position 10-K · filed 2022-02-28 |
employee
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 1 month |
|---|---|
| 2018-12-31 | 240.00 employee 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |